Neurocrine Biosciences to Present at the Deutsche Bank 34th Annual Health Care Conference

Neurocrine Biosciences to Present at the Deutsche Bank 34th Annual Health Care
Conference

LIVE AUDIO WEBCAST MONDAY, MAY 18, 2009

SAN DIEGO, May 11 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc.
(Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief
Executive Officer of Neurocrine Biosciences will be presenting at the Deutsche
Bank 34th Annual Health Care Conference in Boston.

The live presentation takes place Monday, May 18, 2009 at 5:05 p.m. Eastern
Time (ET)/2:05 p.m. Pacific Time (PT). The presentation will be
simultaneously webcast and may be accessed on the Company's website at
http://www.neurocrine.com.

If you are unable to attend the webcast and would like further information on
this announcement please contact the Investor Relations Department at
Neurocrine Biosciences at (858) 617-7600. Viewers are encouraged to visit the
website approximately 5 minutes prior to the presentation to download or
install any necessary software. A replay of the presentation will be
available approximately one hour after the conclusion of the live event and
will be archived on the website for two weeks.

About Neurocrine
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on
neurological and endocrine diseases and disorders. Our product candidates
address some of the largest pharmaceutical markets in the world including
endometriosis, anxiety, depression, pain, diabetes, benign prostatic
hyperplasia (BPH), irritable bowel syndrome (IBS) and other neurological and
endocrine related diseases and disorders. Neurocrine Biosciences, Inc. news
releases are available through the Company's website via the internet at
http://www.neurocrine.com

SOURCE Neurocrine Biosciences, Inc.

Investor Relations of Neurocrine Biosciences, +1-858-617-7600